Physician profile
Melissa E Wood
NPI 1578795134
$405.84
in general payments reported to CMS, 2019-2025
13 companies · $58.41 in 2025
The $58.41 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $319 · 2022: $15.14 · 2023: $13.01 · 2025: $58.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $89.92 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.47 | 2021 | |
| Merck Sharp & Dohme LLC | $40.10 | 2021 | |
| Pfizer INC. | $38.58 | 2021 | |
| Lilly USA, LLC | $38.10 | 2021 | |
| Janssen Pharmaceuticals, INC | $28.06 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $27.78 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $26.09 | 2021 | |
| Inari Medical, INC. | $18.85 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Nestle Healthcare Nutrition INC. | $17.99 | 2021 | |
| Amgen INC. | $14.43 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.05 | 2021 | |
| Xeris Pharmaceuticals, INC. | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.